The Embleema Health Blockchain Update : first pharma partnership announced !
Dear Embleema Blockchain Community,
As we reach new milestones, signing on life sciences partners to join our blockchain for health consortium, our team felt we owed you an update. This is a first of many newsletter to come about product developments, business milestones and upcoming events.
Embleema means…
The centerpiece of a mosaic. Embleema’s blockchain lets patients assemble the complete picture of their health, own their data and opt-in to research with real compensation.
My two cents of the day…
📍 TL;DR…
- Embleema signed its first official partnership with Pierre Fabre Pharmaceuticals this October. The leading pharma in oncology will take part in building Embleema’s decentralized Blockchain Network, hosting nodes to store and share data securely, and mining th to guarantee the security of sensitive data. More coming soon…
- In New York , Robert Chu (CEO of Embleema) shared his experience at Conv2X on the launch of Patient Truth, the first live Blockchain based personal health records.
- In Boston, Alexis Normand (Head of Embleema consortium) presented at Connected Health, the leading conference in the USA on digital health.
- In Paris, we hosted a debate on Blockchain for health with Pierre Person (MP & author of parliamentary report on Blockchain), Dr. Bernard Hamelin (SVP of Evidence Generation at Sanofi), Jean-Marc Aubert (Head of Statistics & Healthcare Financing at French Ministry of Health) Michèle Anahory, (partner at PLBA Law) &Alain-Michel Ceretti (Patient Advocacy Leader & Board Member at French Drug Administration)
Tailwinds…
Advisors John Halamka(CIO of BIDMC) and Dr Vahan Simonyan (former FDA R&D Director of Bioinformatics ) are helping set new standards for sharing Real World Evidence (RWE), with decentralized networks that match the FDA’s analytical framework . More news coming soon…
Business…
Looking good ! After signing on two pharmas, we have now 4 proposals in discussion for partners wishing to take the lead in next generation real world evidence studies through Blockchain. We are also in advanced discussions to advise two countries on their road-map for blockchain in healthcare.
You can help…
We are providing tailored experiences for rare disease patients to better monitor their condition, and enroll more easily in trials, without giving away their control over their data. If you believe patients should control and own their data, get in touch…
🗓 Coming up…
- This week, Robert will present at the World Blockchain Forum in New York and Vincentwill be in Paris to present at the French Public Bank of Investment for the National Conference on Health Data
- On the 13th of November, we are invited by Maria Palombini at the Blockchain for Clinical Trials Forum in Glascow. Lots of new announcements then!
- Meet us at the NGP World of Connections sessions on digital health in SF.
- At the end of the month, Alexis Normand will be in Singapour at Blockshow to meet with investors, and Vincent will be in Monaco for the Blockchain Summit.
- After closing its seed funding, Embleema will begin discussions for its series A, supported by our advisor & friend Dorothée Stik, Director at Messiers & Maris Investment Bank
We will keep you posted on what’s next! To learn more about Embleema’s news, follow us on Telegram, visit us on www.embleema.com or write to us at info@embleema.com.
Sincerely yours,
Alexis
